Chris Judd's Talk Ya Book Podcast · Chris Judd's Talk Ya Book

John Van Der Wielen

December 3, 2024·19 min·1 clip
John van der Wielen describes cutting 25,000 jobs at Lloyds in months and seeing bankers cry on the tube after Lehman collapsed.
Chris Judd interviews John van der Wielen, Chairman of biotech company OrthoCell. The conversation covers van der Wielen's dramatic experiences in London finance during the 2008 crisis before diving deep into OrthoCell's collagen-based medical devices for nerve and dental repair, its high-profile board, and the multi-billion dollar market opportunity pending US FDA approval.

As heard by us

A measured OrthoCell discussion of governance, product rollouts, and the approvals still ahead.

Chris Judd steers this Talk Your Book interview toward OrthoCell's governance and commercial setup, using John van der Wielen to frame the board, the products, and the regulatory path still ahead.

Read the full review in PlayNext →

Why you'd press play

You want a concise read on OrthoCell's chair, governance, products, and approval path.

Read the full recommendation in PlayNext →
Listen to the show on